Latest News & Features
Refine Search
Asia
A court appeal by Bayer against India’s first ever compulsory licence on its patented cancer drug will start today, October 29. 29 October 2013
Americas
The governor of California, Jerry Brown, has refused to sign legislation seeking to introduce changes to the state’s pharmacy law on biosimilars. 29 October 2013
Big Pharma
Mr Justice Arnold has refused to recuse himself from a patent trial after he was accused of being conflicted by an expert witness. 28 October 2013
article
The US District Court for the District of Arizona has rejected technology company W.L. Gore’s motion for a new trial to amend the judgment of its patent dispute with medical device maker C.R. Bard. 24 October 2013
article
British barrister Richard Hacon is set to become the permanent presiding judge of the Intellectual Property Enterprise Court, multiple sources have told WIPR. 22 October 2013
Big Pharma
UK-based pharmaceutical company AstraZeneca announced on October 15 that its biologics R&D subsidiary MedImmune had acquired cancer drug maker Spirogen. 18 October 2013
Big Pharma
Patent litigator Jonathan Radcliffe has left Mayer Brown to become partner at Charles Russell LLP. 16 October 2013
Asia
Many of the world’s biggest selling drugs have lost exclusivity in recent years, presenting huge opportunities for generic drugs companies but, as LSIPR finds out, it doesn’t have to be a dead end for the innovators. 16 October 2013
Biotechnology
Frances Salisbury and Lindsey Woolley look at the complex business of patenting agricultural products in Europe. 16 October 2013
Biotechnology
The Court of Justice of the European Union’s decision in the Brüstle case has worrying implications for some stem cell patents. Andy Sanderson looks at the landscape across Europe. 16 October 2013